Detalhe da pesquisa
1.
Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.
Clin Transl Immunology
; 10(4): e1269, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33841880
2.
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial.
Lancet Infect Dis
; 21(10): 1383-1394, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887208
3.
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study.
Lancet Infect Dis
; 20(4): 445-454, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32027842